Aaron Royston

Aaron E.
Royston was the founder of Red Ventures LLC, founded in 2010, and Rayzebio, Inc., founded in 2020 where the title held was Director from 2020 to 2023.
Current jobs include Board of Directors at HistoWiz, Inc. since 2021; Board Of Director at Swift Health Systems, Inc. since 2019; Director at Neurogastrx, Inc. since 2018; Director at Abbott Pharmaceuticals (Shanghai) Co., Ltd.; Director at Ceptur Therapeutics, Inc.; Director at 35Pharma, Inc. since 2022; Independent Director at Achieve Life Sciences, Inc. starting 2026; Independent Director at Attovia Therapeutics, Inc. since 2023; and Managing Partner at venBio Partners LLC since 2015.
Former jobs include Director at IPI Legacy Liquidation Co. from 2016 to 2021; Independent Director at Menlo Therapeutics, Inc. from 2017 to 2019; Director at Harmony Biosciences Holdings, Inc.; Director at Harmony Biosciences LLC; Independent Non-Executive Director at Akero Therapeutics, Inc. from 2018 to 2019; Independent Director at Ventyx Biosciences, Inc. from 2021 to 2023; and Board of Directors at Apellis Pharmaceuticals, Inc. Education includes undergraduate degree from Duke University and MBA and doctorate degrees from the University of Pennsylvania.